Deutsche Bank analyst Bryan Keane lowered the firm’s price target on Genpact to $37 from $48 and keeps a Hold rating on the shares. The company’s record bookings are offset by lower short-cycle work, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on G: